Archer-Daniels Midland Co has a consensus price target of $75.95 based on the ratings of 21 analysts. The high is $117 issued by Wolfe Research on August 12, 2022. The low is $51 issued by UBS on January 26, 2024. The 3 most-recent analyst ratings were released by Citigroup, Citigroup, and B of A Securities on July 15, 2024, April 3, 2024, and March 14, 2024, respectively. With an average price target of $67 between Citigroup, Citigroup, and B of A Securities, there's an implied 4.72% upside for Archer-Daniels Midland Co from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/15/2024 | Buy Now | -1.53% | Citigroup | Thomas Palmer | $64 → $63 | Maintains | Neutral | Get Alert |
04/03/2024 | Buy Now | 0.03% | Citigroup | David Driscoll | $63 → $64 | Maintains | Neutral | Get Alert |
03/14/2024 | Buy Now | 15.66% | B of A Securities | Salvator Tiano | $85 → $74 | Maintains | Neutral | Get Alert |
03/13/2024 | Buy Now | -6.22% | BMO Capital | Andrew Strelzik | $66 → $60 | Maintains | Market Perform | Get Alert |
03/13/2024 | Buy Now | 1.59% | Jefferies | Dushyant Ailani | $70 → $65 | Maintains | Hold | Get Alert |
02/01/2024 | Buy Now | -10.91% | Citigroup | Thomas Palmer | → $57 | Initiates | → Neutral | Get Alert |
01/26/2024 | Buy Now | -20.29% | UBS | Manav Gupta | $104 → $51 | Downgrade | Buy → Neutral | Get Alert |
01/23/2024 | Buy Now | 4.72% | Goldman Sachs | Adam Samuelson | $90 → $67 | Maintains | Neutral | Get Alert |
01/22/2024 | Buy Now | -6.22% | Barclays | Benjamin Theurer | → $60 | Downgrade | Overweight → Underweight | Get Alert |
01/22/2024 | Buy Now | -12.47% | Stifel | Vincent Anderson | $116 → $56 | Downgrade | Buy → Hold | Get Alert |
01/22/2024 | Buy Now | 3.16% | Roth MKM | Brian Wright | $98 → $66 | Downgrade | Buy → Neutral | Get Alert |
01/22/2024 | Buy Now | 3.16% | BMO Capital | Andrew Strelzik | $80 → $66 | Maintains | Market Perform | Get Alert |
01/22/2024 | Buy Now | 4.72% | Goldman Sachs | Adam Samuelson | $90 → $67 | Downgrade | Buy → Neutral | Get Alert |
01/22/2024 | Buy Now | -4.66% | Baird | Ben Kallo | $96 → $61 | Downgrade | Outperform → Neutral | Get Alert |
12/20/2023 | Buy Now | 62.55% | UBS | Manav Gupta | $115 → $104 | Maintains | Buy | Get Alert |
12/18/2023 | Buy Now | 25.04% | BMO Capital | Andrew Strelzik | → $80 | Downgrade | Outperform → Market Perform | Get Alert |
10/30/2023 | Buy Now | 18.79% | Morgan Stanley | Vincent Andrews | $87 → $76 | Maintains | Equal-Weight | Get Alert |
10/25/2023 | Buy Now | 17.22% | JP Morgan | Thomas Palmer | $77 → $75 | Maintains | Neutral | Get Alert |
10/25/2023 | Buy Now | 17.22% | Stephens & Co. | Ben Bienvenu | $80 → $75 | Maintains | Equal-Weight | Get Alert |
10/19/2023 | Buy Now | 20.35% | JP Morgan | Thomas Palmer | $85 → $77 | Maintains | Neutral | Get Alert |
08/01/2023 | Buy Now | 48.48% | Argus Research | David Coleman | $91 → $95 | Maintains | Buy | Get Alert |
08/01/2023 | Buy Now | 35.98% | Morgan Stanley | Vincent Andrews | $83 → $87 | Maintains | Equal-Weight | Get Alert |
07/31/2023 | Buy Now | 35.98% | Morgan Stanley | Vincent Andrews | $83 → $87 | Maintains | Equal-Weight | Get Alert |
07/17/2023 | Buy Now | 29.73% | Morgan Stanley | Vincent Andrews | $83 → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
06/22/2023 | Buy Now | 43.79% | Roth MKM | Brian Wright | → $92 | Initiates | → Buy | Get Alert |
06/01/2023 | Buy Now | 48.48% | Barclays | Benjamin Theurer | $99 → $95 | Maintains | Overweight | Get Alert |
04/27/2023 | Buy Now | 29.73% | Morgan Stanley | Vincent Andrews | $85 → $83 | Maintains | Equal-Weight | Get Alert |
04/26/2023 | Buy Now | 40.67% | Baird | Ben Kallo | $98 → $90 | Maintains | Outperform | Get Alert |
04/26/2023 | Buy Now | 54.74% | Barclays | Benjamin Theurer | $105 → $99 | Maintains | Overweight | Get Alert |
04/14/2023 | Buy Now | 56.3% | BMO Capital | Andrew Strelzik | → $100 | Reinstates | → Outperform | Get Alert |
04/13/2023 | Buy Now | 56.3% | BMO Capital | Andrew Strelzik | → $100 | Reinstates | → Outperform | Get Alert |
04/13/2023 | Buy Now | 32.85% | Morgan Stanley | Vincent Andrews | $94 → $85 | Maintains | Equal-Weight | Get Alert |
04/12/2023 | Buy Now | 32.85% | JP Morgan | Thomas Palmer | $87 → $85 | Maintains | Neutral | Get Alert |
01/30/2023 | Buy Now | 35.98% | JP Morgan | Tom Simonitsch | $88 → $87 | Maintains | Neutral | Get Alert |
01/19/2023 | Buy Now | 37.54% | JP Morgan | Tom Simonitsch | $84 → $88 | Maintains | Neutral | Get Alert |
01/03/2023 | Buy Now | 81.31% | Stifel | Vincent Anderson | $114 → $116 | Maintains | Buy | Get Alert |
12/14/2022 | Buy Now | 79.74% | UBS | Manav Gupta | → $115 | Initiates | → Buy | Get Alert |
10/26/2022 | Buy Now | 56.3% | BMO Capital | Kenneth Zaslow | $95 → $100 | Maintains | Market Perform | Get Alert |
10/26/2022 | Buy Now | 53.17% | Baird | Ben Kallo | $94 → $98 | Maintains | Outperform | Get Alert |
10/25/2022 | Buy Now | 78.18% | Stifel | Vincent Anderson | $111 → $114 | Maintains | Buy | Get Alert |
10/24/2022 | Buy Now | 56.3% | B of A Securities | Steve Byrne | $104 → $100 | Maintains | Neutral | Get Alert |
10/10/2022 | Buy Now | 31.29% | JP Morgan | Tom Simonitsch | $83 → $84 | Maintains | Neutral | Get Alert |
08/12/2022 | Buy Now | 82.87% | Wolfe Research | Sam Margolin | → $117 | Initiates | → Outperform | Get Alert |
07/27/2022 | Buy Now | 46.92% | Baird | Ben Kallo | $87 → $94 | Maintains | Outperform | Get Alert |
07/07/2022 | Buy Now | 45.36% | JP Morgan | Tom Simonitsch | $83 → $93 | Maintains | Neutral | Get Alert |
06/30/2022 | Buy Now | 54.74% | B of A Securities | Steve Byrne | $103 → $99 | Upgrade | Neutral → Buy | Get Alert |
06/01/2022 | Buy Now | 21.91% | B of A Securities | Steve Byrne | $73 → $78 | Maintains | Buy | Get Alert |
05/02/2022 | Buy Now | 46.92% | Morgan Stanley | Vincent Andrews | $69 → $94 | Maintains | Equal-Weight | Get Alert |
04/27/2022 | Buy Now | 68.8% | Baird | Ben Kallo | $73 → $108 | Maintains | Outperform | Get Alert |
04/27/2022 | Buy Now | 48.48% | BMO Capital | Kenneth Zaslow | $90 → $95 | Maintains | Market Perform | Get Alert |
04/27/2022 | Buy Now | 43.79% | Credit Suisse | Robert Moskow | $80 → $92 | Maintains | Neutral | Get Alert |
04/26/2022 | Buy Now | 73.49% | Stifel | Vincent Anderson | $100 → $111 | Maintains | Buy | Get Alert |
04/22/2022 | Buy Now | 48.48% | Barclays | Benjamin Theurer | $88 → $95 | Maintains | Overweight | Get Alert |
04/19/2022 | Buy Now | — | B of A Securities | Steve Byrne | — | Downgrade | Buy → Neutral | Get Alert |
04/06/2022 | Buy Now | 56.3% | Stifel | Vincent Anderson | $80 → $100 | Maintains | Buy | Get Alert |
03/16/2022 | Buy Now | 42.23% | Goldman Sachs | — | $79 → $91 | Maintains | Buy | Get Alert |
01/26/2022 | Buy Now | 14.1% | Baird | Ben Kallo | $70 → $73 | Maintains | Outperform | Get Alert |
01/26/2022 | Buy Now | 25.04% | Stifel | Vincent Anderson | $78 → $80 | Maintains | Buy | Get Alert |
01/11/2022 | Buy Now | 7.85% | Morgan Stanley | Vincent Andrews | $67 → $69 | Maintains | Equal-Weight | Get Alert |
12/22/2021 | Buy Now | 9.41% | Baird | Ben Kallo | → $70 | Maintains | Outperform | Get Alert |
12/13/2021 | Buy Now | 28.17% | Barclays | Benjamin Theurer | — | Maintains | Overweight | Get Alert |
10/27/2021 | Buy Now | 18.79% | JP Morgan | Tom Simonitsch | $68 → $76 | Maintains | Overweight | Get Alert |
10/12/2021 | Buy Now | 4.72% | Stephens & Co. | Ben Bienvenu | — | Downgrade | Overweight → Equal-Weight | Get Alert |
10/04/2021 | Buy Now | 18.79% | Stifel | Vincent Anderson | → $76 | Maintains | Buy | Get Alert |
The latest price target for Archer-Daniels Midland (NYSE:ADM) was reported by Citigroup on July 15, 2024. The analyst firm set a price target for $63.00 expecting ADM to fall to within 12 months (a possible -1.53% downside). 23 analyst firms have reported ratings in the last year.
The latest analyst rating for Archer-Daniels Midland (NYSE:ADM) was provided by Citigroup, and Archer-Daniels Midland maintained their neutral rating.
The last upgrade for Archer-Daniels Midland Co happened on June 30, 2022 when B of A Securities raised their price target to $99. B of A Securities previously had a neutral for Archer-Daniels Midland Co.
The last downgrade for Archer-Daniels Midland Co happened on January 26, 2024 when UBS changed their price target from $104 to $51 for Archer-Daniels Midland Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Archer-Daniels Midland, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Archer-Daniels Midland was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
While ratings are subjective and will change, the latest Archer-Daniels Midland (ADM) rating was a maintained with a price target of $64.00 to $63.00. The current price Archer-Daniels Midland (ADM) is trading at is $63.98, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.